Au-ACRAMTU-PEt₃ alters redox balance to inhibit T cell proliferation and function

Keyphrases

• T Cell Activation 100%
• T Cell Proliferation 100%
• Redox Balance 100%
• CD8+ T Cells 75%
• T Cells 50%
• Immune Response 50%
• CD4+ 50%
• Immunosuppressive Activity 50%
• Graft-versus-host Disease (GvHD) 25%
• Rheumatoid Arthritis 25%
• Interleukin-17 (IL-17) 25%
• Allergy 25%
• Multiple Sclerosis 25%
• Virus 25%
• Tumor 25%
• Cyclosporine 25%
• Transplantation 25%
• Autoimmunity 25%
• Organ Transplant 25%
• Clinical Impact 25%
• Antitumor Agents 25%
• Interleukin-2 25%
• Autoimmune Disease 25%
• T Cell Response 25%
• Viral Load 25%
• Viral Infection 25%
• Systemic Lupus Erythematosus 25%
• Lymphocyte Proliferation 25%
• New Therapeutics 25%
• Pre-incubation 25%
• Lymphocyte Activation 25%
• Pharmaceutical Grade 25%
• Clinical Problems 25%
• Lymphocyte Function 25%
• Gold(I) 25%
• Gold Complexes 25%
• Platinum-acridine 25%

Immunology and Microbiology

• Cytotoxic T-Cell 100%
• T Cell Proliferation 100%
• Cell Function 100%
• T-Helper Cell 66%
• Immunosuppressive Drug 66%
• T Cell Activation 66%
• Immune Response 66%
• T Cell 66%
• Inflammatory Arthritis 33%
• Graft-Versus-Host Disease 33%
• Autoimmunity 33%
• Viral Disease 33%
• Tumor Necrosis Factor 33%
• Systemic Lupus Erythematosus 33%
• Viral Load 33%
• Multiple Sclerosis 33%
• Ciclosporin 33%
• Cell Proliferation 33%
• Autoimmune Disease 33%
• Interleukin 2 33%
• Lymphocyte Proliferation 33%
• Lymphocyte Function 33%
• Lymphocyte Activation 33%
• Interleukin 17 33%